NIH researchers identify regulatory cells that shield against inflammatory bowel disease - Takeaways - MDSpire

NIH researchers identify regulatory cells that shield against inflammatory bowel disease

  • June 8, 2026

  • 0 min

Share

  • 1

    NIH researchers identified a regulatory pathway crucial for the immune defense against inflammatory bowel disease (IBD).

  • 2

    Harmful mutations in the GPR15 gene are linked to severe, early-onset IBD, affecting the body's immune response.

  • 3

    The study discovered intramucosal GPR15-guided regulatory CD8+ T lymphocytes, which are essential for colon health.

  • 4

    Defective GPR15 variants lead to a lack of protective regulatory cells, causing inflammation due to macrophage accumulation.

  • 5

    The findings suggest potential targeted therapies to restore GPR15 signaling and improve IBD treatment outcomes.

Original Source(s)

Related Content